These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32976906)

  • 21. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
    Kuo YC; Shih-Huang CY
    J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier.
    Nafee N; Gouda N
    Curr Gene Ther; 2017; 17(2):154-169. PubMed ID: 28494740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New technologies for drug delivery across the blood brain barrier.
    Kabanov AV; Batrakova EV
    Curr Pharm Des; 2004; 10(12):1355-63. PubMed ID: 15134486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elucidating the Multi-Targeted Role of Nutraceuticals: A Complementary Therapy to Starve Neurodegenerative Diseases.
    Behl T; Kaur G; Sehgal A; Singh S; Bhatia S; Al-Harrasi A; Zengin G; Bungau SG; Munteanu MA; Brisc MC; Andronie-Cioara FL; Brisc C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotection by curcumin: A review on brain delivery strategies.
    Askarizadeh A; Barreto GE; Henney NC; Majeed M; Sahebkar A
    Int J Pharm; 2020 Jul; 585():119476. PubMed ID: 32473377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanostructures for drug delivery to the brain.
    Martin-Banderas L; Holgado MA; Venero JL; Alvarez-Fuentes J; Fernández-Arévalo M
    Curr Med Chem; 2011; 18(34):5303-21. PubMed ID: 22087827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanostructure-based drug delivery systems for brain targeting.
    Haque S; Md S; Alam MI; Sahni JK; Ali J; Baboota S
    Drug Dev Ind Pharm; 2012 Apr; 38(4):387-411. PubMed ID: 21954902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
    Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
    Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection.
    Surnar B; Basu U; Banik B; Ahmad A; Marples B; Kolishetti N; Dhar S
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12333-E12342. PubMed ID: 30530697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges.
    Gidwani M; Singh AV
    Curr Pharm Biotechnol; 2014; 14(14):1201-12. PubMed ID: 24809717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin.
    Oppong-Damoah A; Zaman RU; D'Souza MJ; Murnane KS
    Horm Behav; 2019 Feb; 108():20-29. PubMed ID: 30593782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation.
    Kanubaddi KR; Yang SH; Wu LW; Lee CH; Weng CF
    Int J Nanomedicine; 2018; 13():8473-8485. PubMed ID: 30587972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticle transport across the blood brain barrier.
    Grabrucker AM; Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G
    Tissue Barriers; 2016; 4(1):e1153568. PubMed ID: 27141426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research advances in brain-targeted nanoscale drug delivery system].
    Liu Y; Jiang C
    Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain Metastases.
    Wyatt EA; Davis ME
    Mol Pharm; 2020 Feb; 17(2):717-721. PubMed ID: 31916770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chapter 1 - Drug delivery to the brain using colloidal carriers.
    Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
    Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.